全球鼻胃管市場

預計到 2030 年全球鼻胃管市場規模將達到 7.001 億美元

全球鼻胃管市場規模預計在2024年達到5.434億美元，預計在2024-2030年的分析期間內將以4.3%的複合年成長率成長，到2030年將達到7.001億美元。成人患者是本報告分析的細分市場之一，預計其複合年成長率將達到4.9%，到分析期結束時將達到3.999億美元。兒科患者細分市場在分析期間的複合年成長率預計為3.7%。

美國市場規模估計為 1.48 億美元，中國市場預計複合年成長率為 8.0%

美國鼻胃管市場規模預計2024年達到1.48億美元。作為世界第二大經濟體，中國市場規模預計在2030年達到1.446億美元，2024年至2030年的複合年成長率為8.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為1.7%和3.4%。在歐洲，預計德國市場的複合年成長率約為2.5%。

全球鼻胃管市場趨勢—主要趨勢與促進因素摘要

鼻胃管市場如何發展以滿足醫療和營養需求？

鼻胃管 (NG 管) 市場取得了重大進展，這得益於材料、設計和應用技術的改進，這些改進提高了患者的舒適度和治療效率。 NG 管廣泛用於經腸營養、藥物管理和胃減壓，使其成為醫院、家庭護理機構和加護病房(ICU) 的重要工具。傳統的聚氯乙烯管正逐漸被更靈活、生物相容性的材料（如矽膠和聚氨酯）所取代。此外，防堵塞和抗菌塗層 NG 管的開發可透過最大限度地減少感染和阻塞來改善患者的預後。吞嚥困難、神經系統疾病和胃腸道疾病的盛行率不斷上升，進一步推動了對鼻胃管的需求，尤其是在老年人口和重症患者中。家庭醫療保健服務的擴展也推動了對長期經腸營養解決方案的需求，使 NG 管成為慢性病管理的重要組成部分。

為什麼各個醫療保健領域對鼻胃管的需求不斷增加？

中風、癌症和神經系統疾病等需要經腸營養的疾病的發生率不斷上升，導致胃腸道管的使用量大幅增加。這些設備在醫院和醫療機構中用於為重症患者提供短期營養支持，而長期照護機構和居家醫療提供者則提供持續的營養支持。頭頸癌的發生率不斷上升，常常導致吞嚥困難，這進一步促進了市場的擴張。此外，胃腸道管在急診和創傷護理中發揮重要作用，它們用於減壓胃部和吸出攝入的毒素。兒科和新生兒護理領域對胃腸道管的需求也在增加，因為早產兒和先天性異常的嬰兒通常需要特殊的餵食方法。此外，需要術後營養支持的外科手術數量不斷增加，尤其是胃腸手術和減重手術，這也加強了胃腸道管市場。

技術創新和監管發展如何影響市場？

鼻胃管產業已出現多項創新，旨在提高安全性、減少併發症和增強患者舒適度。滲透性、顏色編碼鼻胃管引入技術的引入提高了插入位置的確認率（鼻胃管使用中的一個重要問題），並降低了誤插的風險。 pH 敏感指示劑和電磁放置確認系統的開發進一步提高了導管定位的準確性，減少了對 X光確認的依賴並最大限度地減少了輻射暴露。此外，抗菌塗層和水凝膠基鼻胃管因其減少細菌定植和預防感染的能力而越來越受歡迎。 FDA 和歐洲藥品管理局 (EMA) 等監管機構正在實施更嚴格的指導方針，以確保鼻胃管的安全性和有效性，促使製造商投資於高品質的標準化產品。醫療機構越來越重視感染控制和病人安全，預計這將推動對先進鼻胃管解決方案的需求。

推動鼻胃管市場成長要素有哪些？

鼻胃管市場的成長受到多種因素的推動，包括吞嚥困難和胃腸道疾病盛行率的上升、對經腸營養解決方案的需求增加以及導管留置技術的進步。其中一個關鍵促進因素是人口老化，這導致需要長期經腸營養的疾病發生率上升。家庭醫療保健服務的日益普及也發揮關鍵作用，導致越來越多的患者在醫院外接受經腸營養。此外，ICU 設施和重症監護病房的擴建，特別是為應對全球健康危機，刺激了急診和加護治療環境中對 NG 管的需求。對微創醫療程序的日益關注導致了方便用戶使用型 NG 管的開發，這些管可提高安全性、減少併發症並增強患者體驗。此外，對醫療研發的持續投資預計將導致功能增強的下一代 NG 管的推出，從而進一步推動未來幾年的市場成長。

部分

患者類型（成人患者、兒童患者、老年患者）、適應症類型（胃癌、食道癌、發炎性腸道疾病、慢性腎臟病、吞嚥障礙、其他適應症類型）、管類型（小口徑飼管、大口徑飼管）、最終用戶（醫院/護理機構最終用戶、家庭護理最終用戶）

受訪公司範例

• ALCOR Scientific Inc.
• Amsino International, Inc.
• Angiplast Pvt. Ltd.
• Applied Medical Technology, Inc.
• Avanos Medical, Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company（BD）
• Bicakcilar Medical Devices
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Medical Inc.
• Fresenius Kabi AG
• Guangdong Baihe Medical Technology Co. Ltd.
• Hangzhou Formed Medical Devices Co., Ltd.
• Medtronic plc
• Poly Medicure Limited
• QMD（Qosina Medical Devices）
• Securmed SpA（Delta Med）
• Vygon SA

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Nasogastric Tubes Market to Reach US$700.1 Million by 2030

The global market for Nasogastric Tubes estimated at US$543.4 Million in the year 2024, is expected to reach US$700.1 Million by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Adult Patients, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$399.9 Million by the end of the analysis period. Growth in the Pediatric Patients segment is estimated at 3.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$148.0 Million While China is Forecast to Grow at 8.0% CAGR

The Nasogastric Tubes market in the U.S. is estimated at US$148.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$144.6 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Nasogastric Tube Market - Key Trends & Drivers Summarized

How Is the Nasogastric Tube Market Evolving to Meet Medical and Nutritional Needs?

The nasogastric (NG) tube market has undergone significant advancements, with improvements in materials, design, and application techniques that enhance patient comfort and treatment efficiency. NG tubes are widely used for enteral feeding, medication administration, and gastric decompression, serving as a critical tool in hospitals, home care settings, and intensive care units (ICUs). Traditional PVC-based tubes have been gradually replaced by softer, biocompatible materials such as silicone and polyurethane, which offer greater flexibility and reduce the risk of mucosal injury. Additionally, the development of anti-clogging and antimicrobial-coated NG tubes has improved patient outcomes by minimizing infections and obstructions. The increasing prevalence of dysphagia, neurological disorders, and gastrointestinal diseases has further driven the demand for nasogastric tubes, particularly in aging populations and critical care patients. The expansion of home healthcare services has also fueled the need for long-term enteral feeding solutions, making NG tubes an essential component in chronic disease management.

Why Is the Demand for Nasogastric Tubes Rising Across Various Healthcare Segments?

The increasing incidence of conditions that require enteral feeding, such as stroke, cancer, and neurological disorders, has led to a significant rise in the use of NG tubes. Hospitals and healthcare facilities rely on these devices for short-term feeding in critically ill patients, while long-term care facilities and home healthcare providers utilize them for sustained nutritional support. The growing prevalence of head and neck cancers, which often lead to swallowing difficulties, has further contributed to market expansion. Additionally, NG tubes play a vital role in emergency and trauma care, where they are used for gastric decompression and aspiration of ingested toxins. The pediatric and neonatal care segments have also witnessed increased demand for NG tubes, as premature infants and infants with congenital abnormalities often require specialized feeding solutions. Furthermore, the rise in surgical procedures requiring post-operative nutritional management has strengthened the market for NG tubes, particularly in gastrointestinal and bariatric surgeries.

How Are Technological Innovations and Regulatory Developments Shaping the Market?

The nasogastric tube industry has seen several innovations aimed at improving safety, reducing complications, and enhancing patient comfort. The introduction of radiopaque and color-coded NG tubes has improved placement verification and reduced misplacement risks, which are critical concerns in NG tube usage. The development of pH-sensitive indicators and electromagnetic placement verification systems has further enhanced tube positioning accuracy, reducing the reliance on X-ray confirmations and minimizing exposure to radiation. Additionally, antimicrobial coatings and hydrogel-based NG tubes are gaining popularity due to their ability to reduce bacterial colonization and prevent infections. Regulatory agencies such as the FDA and European Medicines Agency (EMA) are implementing stricter guidelines to ensure the safety and efficacy of NG tubes, prompting manufacturers to invest in high-quality and standardized products. As healthcare facilities increasingly prioritize infection control and patient safety, the demand for advanced NG tube solutions is expected to grow.

What Are the Key Growth Drivers Boosting the Nasogastric Tube Market?

The growth in the nasogastric tube market is driven by several factors, including the rising prevalence of dysphagia and gastrointestinal disorders, increasing demand for enteral feeding solutions, and advancements in tube placement technologies. One of the primary drivers is the aging population, which has a higher incidence of conditions requiring long-term enteral nutrition. The growing adoption of home healthcare services has also played a crucial role, as more patients receive enteral feeding outside hospital settings. Additionally, the expansion of ICU facilities and critical care units, particularly in response to global health crises, has fueled demand for NG tubes in emergency and intensive care scenarios. The increasing focus on minimally invasive medical procedures has led to the development of user-friendly NG tubes with improved safety features, reducing complications and enhancing patient experience. Moreover, the continued investment in medical research and development is expected to introduce next-generation NG tubes with enhanced functionality, further propelling market growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Nasogastric Tubes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Patient Type (Adult Patients, Pediatric Patients, Geriatric Patients); Indication Type (Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia, Other Indication Types); Tube Type (Small-Bore Feeding Tubes, Large-Bore Feeding Tubes); End-Use (Hospitals & Nursing Homes End-Use, Home Care End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• ALCOR Scientific Inc.
• Amsino International, Inc.
• Angiplast Pvt. Ltd.
• Applied Medical Technology, Inc.
• Avanos Medical, Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company (BD)
• Bicakcilar Medical Devices
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Medical Inc.
• Fresenius Kabi AG
• Guangdong Baihe Medical Technology Co. Ltd.
• Hangzhou Formed Medical Devices Co., Ltd.
• Medtronic plc
• Poly Medicure Limited
• QMD (Qosina Medical Devices)
• Securmed SpA (Delta Med)
• Vygon SA

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Nasogastric Tubes - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Geriatric and Critically Ill Patient Populations Drive Demand for Long-Term Feeding and Decompression Tubes
  • Increased Incidence of Neurological and Gastrointestinal Disorders Expands Use of Nasogastric Tubes in Hospitals
  • Adoption of Enteral Nutrition in Post-Surgical and Oncology Settings Strengthens Clinical Utility
  • Technological Advancements in Soft-Tip and Radiopaque Tube Designs Improve Safety and Placement Accuracy
  • Growth in ICU and Emergency Care Infrastructure Fuels Demand for Short-Term Gastrointestinal Access Devices
  • Integration of Position Verification Sensors and Imaging Support Tools Enhances Procedural Efficiency
  • Regulatory Guidelines on Enteral Feeding Best Practices Shape Hospital Adoption and Product Standards
  • Expansion of Home Healthcare and Rehabilitation Services Spurs Use of Portable Nasogastric Feeding Kits
  • Use of Antimicrobial Coatings and Biocompatible Polymers Reduces Infection Risks and Enhances Acceptance
  • Rising Awareness of Malnutrition Management in Elderly and Pediatric Populations Supports Early Tube Placement
  • Training Programs for Nurses and Primary Care Providers Increase Comfort with Bedside Insertion Techniques
  • Growth in Demand for Pre-Lubricated and Ready-to-Use Nasogastric Tubes Improves Emergency Response Capabilities
  • Development of Multi-Port and Dual-Lumen Tubes Supports Simultaneous Drainage and Nutrition Delivery
  • Product Differentiation Through Material Flexibility and Kink Resistance Enhances Patient Comfort
  • Focus on Minimizing Tube Misplacement Risks Drives Adoption of Guidewire and Electromagnetic Navigation Systems
  • Availability of Cost-Effective Disposable Tube Options Supports Widespread Use in Resource-Limited Settings
  • Health System Emphasis on Early Nutritional Intervention Propels Nasogastric Tube Utilization in Recovery Plans
  • Manufacturer Collaboration with Dietitians and Gastroenterologists Drives Patient-Centric Product Innovation
  • Global Health Crises and Hospitalization Surges Highlight Critical Role of Nasogastric Tubes in Acute Care
  • Clinical Research on Dwell Time and Tube-Related Complications Informs Design Improvements and Best Practices
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Nasogastric Tubes Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Nasogastric Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Nasogastric Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Nasogastric Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Adult Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Adult Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Adult Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Pediatric Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Pediatric Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Pediatric Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Geriatric Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Geriatric Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Geriatric Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Small-Bore Feeding Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Small-Bore Feeding Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Small-Bore Feeding Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Large-Bore Feeding Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Large-Bore Feeding Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Large-Bore Feeding Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals & Nursing Homes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals & Nursing Homes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals & Nursing Homes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Home Care End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Home Care End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Home Care End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Stomach Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Stomach Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Stomach Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Esophageal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for IBD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for IBD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for IBD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Chronic Kidney Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Chronic Kidney Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Chronic Kidney Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Dysphagia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Dysphagia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Dysphagia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Indication Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Indication Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Other Indication Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• JAPAN
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• CHINA
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 80: China Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• EUROPE
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Nasogastric Tubes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Nasogastric Tubes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• FRANCE
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 107: France Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• GERMANY
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 143: UK Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Nasogastric Tubes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• INDIA
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 218: India Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Nasogastric Tubes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Nasogastric Tubes by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Nasogastric Tubes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Nasogastric Tubes by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030
• AFRICA
  • Nasogastric Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Nasogastric Tubes by Patient Type - Adult Patients, Pediatric Patients and Geriatric Patients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Nasogastric Tubes by Patient Type - Percentage Breakdown of Value Sales for Adult Patients, Pediatric Patients and Geriatric Patients for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Nasogastric Tubes by Tube Type - Small-Bore Feeding Tubes and Large-Bore Feeding Tubes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Nasogastric Tubes by Tube Type - Percentage Breakdown of Value Sales for Small-Bore Feeding Tubes and Large-Bore Feeding Tubes for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Nasogastric Tubes by End-Use - Hospitals & Nursing Homes End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Nasogastric Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes End-Use and Home Care End-Use for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Nasogastric Tubes by Indication Type - Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Nasogastric Tubes by Indication Type - Percentage Breakdown of Value Sales for Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia and Other Indication Types for the Years 2015, 2025 & 2030

IV. COMPETITION